Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non‐small cell lung cancer patients

BACKGROUND: Growing evidence indicates that high phosphoserine phosphatase (PSPH) expression is associated with tumor prognosis in many types of cancers. However, the role of PSPH in non‐small cell lung cancer (NSCLC) is unclear. The purpose of this study was to investigate the clinical significance...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Li, Yu, Huajian, Ge, Mengxi, Zhan, Qiong, Huang, Ruofan, Ji, Xiaoyu, Liang, Xiaohua, Zhou, Xinli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500996/
https://www.ncbi.nlm.nih.gov/pubmed/30977310
http://dx.doi.org/10.1111/1759-7714.13064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500996/
https://www.ncbi.nlm.nih.gov/pubmed/30977310
http://dx.doi.org/10.1111/1759-7714.13064

Ejemplares similares